Mode
Text Size
Log in / Sign up

Narrative review proposes time window framework for post-infarction ventricular remodeling interventionNew model for heart repair needs direct testing before doctors can use it

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the proposed time-window framework for post-infarction remodeling as a conceptual model needing validation.

This is a narrative review that proposes a conceptual framework for time-window-based combination strategies to address post-infarction ventricular remodeling. The authors synthesize existing evidence to outline a paradigm for precision intervention, but they do not report pooled effect sizes, study populations, or specific interventions, as this is not a primary trial.

The main argument is that a time-based approach could guide combination therapies, though the authors note that several components of this model are based on preliminary or indirect evidence and await independent confirmation. The proposed conceptual framework requires direct experimental validation.

Key limitations acknowledged by the authors include the preliminary nature of some evidence and the need for direct validation. The review does not report safety data, adverse events, or specific clinical outcomes.

Practice relevance is framed as the potential for a new paradigm, but the authors caution against claims of causation or effectiveness without clinical trial data. The framework integrates existing evidence but requires direct experimental validation.

Heart attacks leave scars that change how the heart pumps. This review looks at a new way to fix that damage using specific timing for treatments. The idea is to combine different strategies based on exactly when the injury happened. This approach could lead to more precise care for patients struggling with heart failure after a major event. However, the current evidence for this plan comes from preliminary studies or indirect data. It has not yet been tested in direct experiments on people. The authors admit that several parts of this model need independent confirmation before they can be trusted. Without more proof, we cannot say this method works better than what is done today. The proposed plan requires direct experimental validation to move from theory to practice. Until then, doctors should wait for solid trial data before adopting these new time-based strategies.

What this means for you:
This new heart repair model needs direct testing before it can guide patient care.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Mitochondrial DNA (mtDNA) has long been recognized as an intracellular damage−associated molecular pattern, but emerging evidence reveals its role as an intercellular messenger driving post−infarction ventricular remodeling. This review systematically elaborates the transition of mtDNA from an “intracellular DAMP” to an “intercellular messenger” and proposes a conceptual framework termed the “three−threshold model”, which integrates existing evidence but requires direct experimental validation. The three thresholds are defined as the release threshold (mitophagy−controlled mtDNA leakage), the transmission threshold (efficiency of intercellular transfer), and the activation threshold (sensitivity of STING signaling). mtDNA is transferred between cells via four modes—naked mtDNA, Ambra1+ sEVs, mt−sEVs, and intact mitochondria—mediating inflammation, fibrosis, and vascular dysfunction, respectively. These pathological effects continuously lower all three thresholds through positive feedback loops, driving irreversible remodeling. Time−window−based combination strategies offer a new paradigm for precision intervention. This framework integrates the entire process from mtDNA generation to intercellular transfer and downstream signaling, providing a systematic basis for precision intervention in post−infarction remodeling. Importantly, several components of this model are based on preliminary or indirect evidence and await independent confirmation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.